KANTARO
LIVE

Serial Number

88922039

Owner

Kantaro Biosciences LLC

Attorney

Michelle A. Cooke

First Use Date

Aug 14, 2020

Filing Date

May 18, 2020

Add to watchlist:

No watchlists yet
View on USPTO

KANTARO Trademark

Serial Number: 88922039 • Registration: 6667510

KANTARO is a trademark filed by Kantaro Biosciences LLC on May 18, 2020. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Kantaro Biosciences LLC (13 trademarks)

1460 Broadway
New York, NY 10036

Entity Type: 16

Trademark Details

Filing Date

May 18, 2020

Registration Date

March 8, 2022

First Use Anywhere

August 14, 2020

First Use in Commerce

August 28, 2020

Published for Opposition

May 18, 2021

Goods & Services

Medical diagnostic testing and analysis equipment and apparatus for performing serological, molecular polymerase chain reaction (PCR), antigen and antibody tests, namely, medical diagnostic apparatus for testing for infections, viruses, disorders and diseases; Blood testing apparatus; Medical apparatus for collecting, processing and testing blood, bodily fluids, biological and cellular samples and specimens and tissue; Medical diagnostic instruments for the analysis of blood, body fluids, biological and cellular samples and specimens and tissue; Apparatus for analysis of biological materials for medical purposes; Medical apparatus and instruments for diagnostic analysis, clinical diagnosis and treatment of infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Tools and devices for medical diagnostics for detecting, measuring and analyzing DNA, RNA, antibodies, enzymes, antigens, viral, infectious, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases, viruses and infections for medical and clinical purposes; Medical apparatus, instruments and devices for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Kits for testing for the presence of antibodies in blood, biological fluids, bodily fluids, biological and cellular samples and specimens and tissue for medical purposes; Medical diagnostic apparatus and devices for detecting SARS-CoV-2 and COVID-19; Diagnostic apparatus for detecting infection; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Medical bags, pouches and containers for the collection and preservation and transport of blood, biofluids, bodily fluids, biological and cellular samples and specimens and tissue obtained from humans

Filing History

REGISTERED-PRINCIPAL REGISTER
Mar 8, 2022 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 1, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 31, 2022 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 28, 2022 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 28, 2022 AITU
USE AMENDMENT FILED
Jan 13, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 13, 2022 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 13, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 18, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 18, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 28, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 13, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 13, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 13, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 13, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 13, 2021 CNEA
ASSIGNED TO EXAMINER
Apr 1, 2021 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 1, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 26, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 8, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 8, 2020 GNRT
NON-FINAL ACTION WRITTEN
Nov 8, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 7, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 3, 2020 NWOS
NEW APPLICATION ENTERED
May 21, 2020 NWAP